Halbert Hargrove Global Advisors, LLC Natera, Inc. Put Options Transaction History

Halbert Hargrove Global Advisors, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 13, 2022	SELL	$30.32 - $91.33 $142,504 - $429,251	-4,700 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$86.26 - $119.0 $241,528 - $333,200	-2,800 Reduced 37.33%	4,700 $439,000
Q2 2021 Jul 29, 2021	SELL	$86.05 - $119.72 $129,075 - $179,580	-1,500 Reduced 16.67%	7,500 $851,000
Q1 2021 May 06, 2021	BUY	$91.47 - $124.36 $823,230 - $1.12 Million	9,000 New	9,000 $914,000

738

124M

590K

246K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $19.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Halbert Hargrove Global Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Halbert Hargrove Global Advisors, LLC with notifications on news.